Experience of mandatory nucleic acid test (NAT) screening across all blood organizations in Germany: NAT yield versus breakthrough transmissions

Transfusion

Volumn 49, Issue 9, 2009, Pages 1850-1858

  Nübling, C Micha ^a   Heiden, Margarethe ^a   Chudy, Michael ^a   Kress, Julia ^a   Seitz, Rainer ^a   Keller Stanislawski, Brigitte ^a   Funk, Markus B ^a  

^a PAUL EHRLICH INSTITUT   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS RNA;

ARTICLE; BLOOD DONOR; BLOOD TRANSFUSION; BLOOD TRANSFUSION REACTION; BREAKTHROUGH TRANSMISSION; DIAGNOSTIC ACCURACY; GENOTYPE; GERMANY; HEPATITIS C VIRUS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; MANDATORY TESTING; NONHUMAN; NUCLEIC ACID ANALYSIS; NUCLEIC ACID TESTING; OUTCOME ASSESSMENT; QUANTITATIVE ANALYSIS; SCREENING TEST; VIRUS DETECTION; VIRUS LOAD; VIRUS TRANSMISSION;

BLOOD; BLOOD BANKS; GERMANY; HEPACIVIRUS; HEPATITIS C; HIV INFECTIONS; HIV SEROPOSITIVITY; HIV-1; HUMANS; MANDATORY TESTING;

EID: 69249177072     PISSN: 00411132     EISSN: 15372995     Source Type: Journal    
DOI: 10.1111/j.1537-2995.2009.02212.x     Document Type: Article

References (31)

1. Directive 2002/98/EC of the European Parliament and of the Council of 27 January 2003 setting standards of quality and safety for the collection, testing, processing, storage and distribution of human blood and blood components and amending Directive 2001/83/EC. Official J Eur Union 2003 L33/30 L33/40.
2. Seitz R, Heiden M, Nubling CM, Unger G, Lower J. The harmonization of the regulation of blood products: a European perspective. Vox Sang 2008 94 : 267 76.
3. Nubling CM, Unkelbach U, Chudy M, Seitz R. Effect of viral nucleic acid testing on contamination frequency of manufacturing plasma pools. Transfusion 2008 48 : 822 6.
4. Stufenplan: Bekanntmachung über die Ergebnisse des Stufenplanverfahrens zur Verminderung des Risikos von Hepatitis B -, Hepatitis C- und HIV-Infektionen bei Empfängern von Erythrozytenkonzentraten (BAnz. Nr. 63 vom 04.04.97, S. 4477) vom 25.Februar 1998. Bundesanzeiger 1998 53 : 3835.
5. Stufenplan: Verminderung des Risikos von HIV -1 - Infektionen durch zelluläre Blutprodukte und gefrorenes Frischplasma Anordnung der Testung auf HIV -1-RNA mit Nukleinsäure-Amplifikationstechniken. Bundesanzeiger 2003 103 : 12269.
6. Saldanha J, Lelie N, Heath A. Establishment of the first international standard for nucleic acid amplification technology (NAT) assays for HCV RNA. WHO Collaborative Study Group. Vox Sang 1999 76 : 149 58.
7. Holmes H, Davis C, Heath A, Hewlett I, Lelie N. An international collaborative study to establish the 1st international standard for HIV-1 RNA for use in nucleic acid-based techniques. J Virol Methods 2001 92 : 141 50.
8. Margaritis AR, Brown SM, Seed CR, Kiely P, D'Agostino B, Keller AJ. Comparison of two automated nucleic acid testing systems for simultaneous detection of human immunodeficiency virus and hepatitis C virus RNA and hepatitis B virus DNA. Transfusion 2007 47 : 1783 93.
9. Assal A, Barlet V, Deschaseaux M, Dupont I, Gallian P, Guitton C, Morel P, David B, De Micco P. Comparison of the analytical and operational performance of two viral nucleic acid test blood screening systems: Procleix Tigris and cobas s 201. Transfusion 2008 Nov 4. [Epub ahead of print 2006 49 : 940 57.
10. Schosser R, Keller-Stanislawski B, Nubling CM, Lower J. Causality assessment of suspected virus transmission by human plasma products. Transfusion 2001 41 : 1020 9.
11. Kretzschmar E, Chudy M, Nubling CM, Ross RS, Kruse F, Trobisch H. First case of hepatitis C virus transmission by a red blood cell concentrate after introduction of nucleic acid amplification technique screening in Germany: a comparative study with various assays. Vox Sang 2007 92 : 297 301.
12. Schmidt M, Korn K, Nuebling CM, Chudy M, Kress J, Horst HA, Geusendam G, Hennig H, Sireis W, Rabenau H, Doerr HW, Berger A, Hourfar MK, Gubbe K, Karl A, Fickenscher H, Tischer K, Babiel R, Seifried E, Guertler L. First transmission of HIV-1 by a cellular blood product after mandatory nucleic acid screening in Germany. Transfusion 2009 49 : in press.
13. Muller-Breitkreutz K. Results of viral marker screening of unpaid blood donations and probability of window period donations in 1997. EPFA Working Group on Quality Assurance. Vox Sang 2000 78 : 149 57.
14. Schreiber GB, Glynn SA, Satten GA, Kong F, Wright D, Busch MP, Tu Y, Kleinman SH. HIV seroconverting donors delay their return: screening test implications. Transfusion 2002 42 : 414 21.
15. Velati C, Romano L, Fomiatti L, Baruffi L, Zanetti AR. Impact of nucleic acid testing for hepatitis B virus, hepatitis C virus, and human immunodeficiency virus on the safety of blood supply in Italy: a 6-year survey. Transfusion 2008 48 : 2205 13.
16. Hourfar MK, Jork C, Schottstedt V, Weber-Schehl M, Brixner V, Busch MP, Geusendam G, Gubbe K, Mahnhardt C, Mayr-Wohlfart U, Pichl L, Roth WK, Schmidt M, Seifried E, Wright DJ German Red Cross NAT Study Group. Experience of German Red Cross blood donor services with nucleic acid testing: results of screening more than 30 million blood donations for human immunodeficiency virus-1, hepatitis C virus, and hepatitis B virus. Transfusion 2008 48 : 1558 66.
17. Orton SL, Stramer SL, Dodd RY, Alter MJ. Risk factors for HCV infection among blood donors confirmed to be positive for the presence of HCV RNA and not reactive for the presence of anti-HCV. Transfusion 2004 44 : 275 81.
18. Bericht zur Meldung nach §22 TFG für die Jahre 1999 und 2000. Bundesgesundheitsbl - Gesundheitsforsch - Gesundheitsschutz 2004 47 : 156 64.
19. Bericht des Robert-Koch-Institutes zu den Meldungen nach §22 Transfusionsgesetz für die Jahre 2001 und 2002. Bundesgesundheitsbl - Gesundheitsforsch - Gesundheitsschutz 2004 47 : 1216 29.
20. Infektionsepidemiologische Daten von Blutspendern 2003-2004. Bundesgesundheitsbl - Gesundheitsforsch - Gesundheitsschutz 2005 48 : 1273 88.
21. Infektionsepidemiologische Daten von Blutspendern 2005. Bundesgesundheitsbl - Gesundheitsforsch - Gesundheitsschutz 2007 50 : 1221 31.
22. Grabarczyk P, Gronowska A, Brojer E, Letowska M, Radziwon P. Sequence analysis confirmation of transfusion-transmitted hepatitis C by red blood cells that tested negative by minipool hepatitis C virus nucleic acid testing. Transfusion 2007 47 : 1102 4.
23. Schuttler CG, Caspari G, Jursch CA, Willems WR, Gerlich WH, Schaefer S. Hepatitis C virus transmission by a blood donation negative in nucleic acid amplification tests for viral RNA. Lancet 2000 355 : 41 2.
24. Humpe A, Legler TJ, Nubling CM, Riggert J, Unger G, Wolf C, Heermann KH, Kohler M. Hepatitis C virus transmission through quarantine fresh-frozen plasma. Thromb Haemost 2000 84 : 784 8.
25. Nubling CM, Unger G, Chudy M, Raia S, Lower J. Sensitivity of HCV core antigen and HCV RNA detection in the early infection phase. Transfusion 2002 42 : 1037 45.
26. Ferreira MC, Nel TJ. Differential transmission of human immunodeficiency virus (HIV) via blood components from an HIV-infected donor. Transfusion 2006 46 : 156 7.
27. Kleinman S, van Drimmelen H, Lelie N, Busch M. Minipool NAT HIV 1 breakthrough transmission cases and probability of interdiction by current small pool or individual donation NAT screening systems. Abstract at XIXth Regional Congress of the ISBT - Eastern Mediterranean and Europe. March 21-25, 2009. Cairo (Egypt).
28. Fauci AS. Resistance to HIV-1 infection: it's in the genes. Nat Med 1996 2 : 966 7.
29. Samson M, Libert F, Doranz BJ, Rucker J, Liesnard C, Farber CM, Saragosti S, Lapoumeroulie C, Cognaux J, Forceille C, Muyldermans G, Verhofstede C, Burtonboy G, Georges M, Imai T, Rana S, Yi Y, Smyth RJ, Collman RG, Doms RW, Vassart G, Parmentier M. Resistance to HIV-1 infection in Caucasian individuals bearing mutant alleles of the CCR-5 chemokine receptor gene. Nature 1996 382 : 722 5.
30. Biswas R, Tabor E, Hsia CC, Wright DJ, Laycock ME, Fiebig EW, Peddada L, Smith R, Schreiber GB, Epstein JS, Nemo GJ, Busch MP. Comparative sensitivity of HBV NATs and HBsAg assays for detection of acute HBV infection. Transfusion 2003 43 : 788 98.
31. Stufenplan: Abwehr von Arzneimittelrisiken; Testung auf Antikörper gegen Hepatitis-B-Core-Antigen (anti-HBc) im Blutspendewesen. Bundesanzeiger 2006 109 : 4370.